Literature DB >> 8904668

Evaluation of a protective immunity induced by an inactivated influenza H3N2 vaccine after an intratracheal challenge of pigs.

M H Bikour1, E Cornaglia, Y Elazhary.   

Abstract

A challenge study was conducted to evaluate the safety and efficacy of an inactivated influenza H3N2 virus vaccine combined with Quil A/Alhydrogel mixture under controlled conditions in piglets. Twenty-four piglets from 12 sows were allocated to 2 groups; injected intramuscularly with 2 doses of the tested vaccine or with PBS at 2 wk intervals and challenged intratracheally with 105TCID50 of the H3N2 swine influenza virus 6 d after the 2nd immunization. Clinical and virological parameters were recorded for 4 d after the challenge. The use of the tested vaccine produced high serum hemagglutination-inhibition titers against the swine H3N2 strain virus. This strong immune response suppressed all clinical signs and viral shedding and reduced pulmonary lesions due to the challenge in the vaccinated group, without causing any secondary effects. Our results suggest that the serum HI titers correlated with the degree of protection induced by an inactivated swine influenza H3N2 vaccine.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8904668      PMCID: PMC1263854     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  10 in total

1.  Severe proliferative and necrotizing pneumonia in pigs: A newly recognized disease.

Authors:  M Morin; C Girard; Y Elazhary; R Fajardo; R Drolet; A Lagacé
Journal:  Can Vet J       Date:  1990-12       Impact factor: 1.008

2.  Epizootics of respiratory tract disease in swine in Belgium due to H3N2 influenza virus and experimental reproduction of disease.

Authors:  F Haesebrouck; P Biront; M B Pensaert; J Leunen
Journal:  Am J Vet Res       Date:  1985-09       Impact factor: 1.156

3.  Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus.

Authors:  M L Clements; R F Betts; E L Tierney; B R Murphy
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

4.  Hong Kong A-2 influenza virus infection among swine during a human epidemic in Taiwan.

Authors:  W D Kundin
Journal:  Nature       Date:  1970-11-28       Impact factor: 49.962

5.  Prevalence of antibodies to porcine enteroviruses and porcine parvovirus in body fluids of fetal pigs from small vs large litters.

Authors:  M Cropper; H W Dunne; A D Leman; A L Starkey; D C Hoefling
Journal:  J Am Vet Med Assoc       Date:  1976-02-01       Impact factor: 1.936

6.  Vaccination of swine against H3N2-influenza field isolates using the human Philippines-strain.

Authors:  F Haesebrouck; M Pensaert; R Wyffels
Journal:  Vet Q       Date:  1987-01       Impact factor: 3.320

7.  Effect of intratracheal challenge of fattening pigs previously immunised with an inactivated influenza H1N1 vaccine.

Authors:  F Haesebrouck; M B Pensaert
Journal:  Vet Microbiol       Date:  1986-03       Impact factor: 3.293

8.  Influenza viral infection of swine in the United States 1988-1989.

Authors:  T M Chambers; V S Hinshaw; Y Kawaoka; B C Easterday; R G Webster
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

9.  Evaluation of A/New Jersey/76 influenza whole-virus vaccine in hysterectomy-derived pigs.

Authors:  E C Pirtle
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

10.  Infection and vaccination of pigs with influenza A/New Jersey/8/76 (Hsw1N1) virus.

Authors:  B C Easterday; B R Murphy; S McGregor
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

  10 in total
  10 in total

1.  Live attenuated influenza vaccine provides superior protection from heterologous infection in pigs with maternal antibodies without inducing vaccine-associated enhanced respiratory disease.

Authors:  Amy L Vincent; Wenjun Ma; Kelly M Lager; Jürgen A Richt; Bruce H Janke; Matthew R Sandbulte; Philip C Gauger; Crystal L Loving; Richard J Webby; Adolfo García-Sastre
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

2.  DNA vaccination elicits protective immune responses against pandemic and classic swine influenza viruses in pigs.

Authors:  J Patrick Gorres; Kelly M Lager; Wing-Pui Kong; Michael Royals; John-Paul Todd; Amy L Vincent; Chih-Jen Wei; Crystal L Loving; Eraldo L Zanella; Bruce Janke; Marcus E Kehrli; Gary J Nabel; Srinivas S Rao
Journal:  Clin Vaccine Immunol       Date:  2011-09-14

3.  Intranasal vaccination with replication-defective adenovirus type 5 encoding influenza virus hemagglutinin elicits protective immunity to homologous challenge and partial protection to heterologous challenge in pigs.

Authors:  Douglas R Braucher; Jamie N Henningson; Crystal L Loving; Amy L Vincent; Eun Kim; Julia Steitz; Andrea A Gambotto; Marcus E Kehrli
Journal:  Clin Vaccine Immunol       Date:  2012-08-29

4.  Vaccine-Associated Enhanced Respiratory Disease following Influenza Virus Infection in Ferrets Recapitulates the Model in Pigs.

Authors:  J Brian Kimble; Meghan Wymore Brand; Bryan S Kaplan; Phillip Gauger; Elizabeth M Coyle; Katarina Chilcote; Surender Khurana; Amy L Vincent
Journal:  J Virol       Date:  2022-01-05       Impact factor: 6.549

5.  Efficacy of swine influenza A virus vaccines against an H3N2 virus variant.

Authors:  Jee Hoon Lee; Marie René Gramer; Han Soo Joo
Journal:  Can J Vet Res       Date:  2007-07       Impact factor: 1.310

6.  Protective efficacy of a broadly cross-reactive swine influenza DNA vaccine encoding M2e, cytotoxic T lymphocyte epitope and consensus H3 hemagglutinin.

Authors:  Bin Wang; Hai Yu; Fu-Ru Yang; Meng Huang; Ji-Hong Ma; Guang-Zhi Tong
Journal:  Virol J       Date:  2012-06-27       Impact factor: 4.099

7.  Conserved HA-peptide NG34 formulated in pCMV-CTLA4-Ig reduces viral shedding in pigs after a heterosubtypic influenza virus SwH3N2 challenge.

Authors:  Marta Sisteré-Oró; Júlia Vergara-Alert; Thomas Stratmann; Sergi López-Serrano; Sonia Pina-Pedrero; Lorena Córdoba; Mónica Pérez-Maillo; Patrícia Pleguezuelos; Enric Vidal; Veljko Veljkovic; Joaquim Segalés; Jens Nielsen; Anders Fomsgaard; Ayub Darji
Journal:  PLoS One       Date:  2019-03-01       Impact factor: 3.240

8.  DNA vaccine based on conserved HA-peptides induces strong immune response and rapidly clears influenza virus infection from vaccinated pigs.

Authors:  Marta Sisteré-Oró; Sergi López-Serrano; Veljko Veljkovic; Sonia Pina-Pedrero; Júlia Vergara-Alert; Lorena Córdoba; Mónica Pérez-Maillo; Patrícia Pleguezuelos; Enric Vidal; Joaquim Segalés; Jens Nielsen; Anders Fomsgaard; Ayub Darji
Journal:  PLoS One       Date:  2019-09-25       Impact factor: 3.240

Review 9.  Optimal Use of Vaccines for Control of Influenza A Virus in Swine.

Authors:  Matthew R Sandbulte; Anna R Spickler; Pamela K Zaabel; James A Roth
Journal:  Vaccines (Basel)       Date:  2015-01-30

10.  α-Galactosylceramide protects swine against influenza infection when administered as a vaccine adjuvant.

Authors:  Bianca L Artiaga; Guan Yang; Timothy J Hackmann; Qinfang Liu; Jürgen A Richt; Shahram Salek-Ardakani; William L Castleman; John A Lednicky; John P Driver
Journal:  Sci Rep       Date:  2016-03-23       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.